Sign in or create an account to add this stock to your watchlist.
About WuXi PharmaTech (Cayman) (NYSE:WX)
WuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:WX
CUSIPN/A
WebN/A
Phone+86-21-50461111
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.52%
Return on Equity6.93%
Return on Assets4.67%
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
WuXi PharmaTech (Cayman) (NYSE:WX) Frequently Asked Questions
What is WuXi PharmaTech (Cayman)'s stock symbol?
WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."
How were WuXi PharmaTech (Cayman)'s earnings last quarter?
WuXi PharmaTech (Cayman) Inc. (NYSE:WX) announced its quarterly earnings data on Tuesday, November, 3rd. The medical research company reported $0.31 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.31. The medical research company earned $213.60 million during the quarter, compared to the consensus estimate of $205.24 million. WuXi PharmaTech (Cayman) had a return on equity of 6.93% and a net margin of 7.52%. The business's revenue for the quarter was up 23.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.54 EPS. View WuXi PharmaTech (Cayman)'s Earnings History.
Has WuXi PharmaTech (Cayman) been receiving favorable news coverage?
News coverage about WX stock has trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. WuXi PharmaTech (Cayman) earned a media sentiment score of 0.21 on Accern's scale. They also assigned news articles about the medical research company an impact score of 47.67 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of WuXi PharmaTech (Cayman)?
Shares of WX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WuXi PharmaTech (Cayman)'s stock price today?
One share of WX stock can currently be purchased for approximately $45.91.
How big of a company is WuXi PharmaTech (Cayman)?
WuXi PharmaTech (Cayman) has a market capitalization of $3.27 billion.
How can I contact WuXi PharmaTech (Cayman)?
WuXi PharmaTech (Cayman)'s mailing address is 288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone, SHANGHAI, SHA 200131, China. The medical research company can be reached via phone at +86-21-50461111.
MarketBeat Community Rating for WuXi PharmaTech (Cayman) (WX)
MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe WX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WX will underperform the S&P 500 over the long term. You may vote once every thirty days.
WuXi PharmaTech (Cayman) (NYSE:WX) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 5/24/2016 forward)
WuXi PharmaTech (Cayman) (NYSE:WX) Earnings History and Estimates Chart
WuXi PharmaTech (Cayman) (NYSE WX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/3/2015 | Q3 | $0.31 | $0.31 | $205.24 million | $213.60 million | View | N/A |  |
| 8/13/2015 | Q215 | $0.39 | $0.38 | $195.26 million | $194.14 million | View | Listen | |
| 5/13/2015 | Q1 | $0.32 | $0.36 | $174.29 million | $180.00 million | View | Listen | |
| 3/5/2015 | Q414 | $0.53 | $0.55 | $189.54 million | $190.60 million | View | Listen | |
| 11/12/2014 | Q314 | $0.48 | $0.54 | $172.60 million | $173.60 million | View | Listen | |
| 8/13/2014 | Q214 | $0.47 | $0.49 | $162.11 million | $163.40 million | View | Listen | |
| 5/14/2014 | Q114 | $0.39 | $0.30 | $145.00 million | $146.70 million | View | Listen | |
| 3/5/2014 | Q413 | $0.43 | $0.53 | $155.76 million | $157.10 million | View | N/A | |
| 11/13/2013 | Q313 | $0.39 | $0.47 | $145.29 million | $146.70 million | View | Listen | |
| 8/12/2013 | Q2 2013 | $0.39 | $0.46 | $141.10 million | $142.33 million | View | N/A | |
| 5/13/2013 | Q1 2013 | $0.32 | $0.35 | $130.02 million | $131.90 million | View | Listen | |
| 3/7/2013 | Q4 2012 | $0.30 | $0.38 | $123.71 million | $125.70 million | View | Listen | |
| 11/12/2012 | Q312 | $0.30 | $0.36 | $123.17 million | $125.84 million | View | N/A | |
| 8/13/2012 | | $0.30 | $0.33 | | | View | N/A | |
| 5/10/2012 | | $0.26 | $0.33 | | | View | N/A | |
| 3/8/2012 | | $0.26 | $0.31 | | | View | N/A | |
| 11/10/2011 | | $0.27 | $0.31 | | | View | N/A | |
| 8/10/2011 | Q2 2011 | $0.25 | $0.25 | | | View | N/A | |
| 5/10/2011 | Q1 2011 | $0.22 | $0.25 | | | View | N/A | |
| 3/8/2011 | Q4 2010 | $0.21 | $0.24 | | | View | N/A | |
| 11/9/2010 | Q3 2010 | $0.43 | $0.27 | | | View | N/A | |
| 8/2/2010 | Q2 2010 | $0.20 | $0.18 | | | View | N/A | |
| 5/11/2010 | Q1 2010 | $0.19 | $0.22 | | | View | N/A | |
| 3/8/2010 | Q4 2009 | $0.16 | $0.17 | | | View | N/A | |
| 11/16/2009 | Q3 2009 | $0.15 | $0.20 | | | View | N/A | |
| 8/11/2009 | Q2 2009 | $0.12 | $0.20 | | | View | N/A | |
| 5/14/2009 | Q1 2009 | $0.08 | $0.16 | | | View | N/A | |
| 3/25/2009 | Q4 2008 | $0.06 | $0.10 | | | View | N/A | |
| 11/12/2008 | Q3 2008 | $0.10 | $0.18 | | | View | N/A | |
| 8/13/2008 | Q2 2008 | $0.18 | $0.17 | | | View | N/A | |
| 5/27/2008 | Q1 2008 | $0.14 | $0.19 | | | View | N/A | |
| 3/12/2008 | Q4 2007 | $0.12 | $0.17 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
WuXi PharmaTech (Cayman) (NYSE:WX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
WuXi PharmaTech (Cayman) (NYSE WX) Insider Trading and Institutional Ownership History
WuXi PharmaTech (Cayman) (NYSE WX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
WuXi PharmaTech (Cayman) (NYSE WX) News Headlines
| Source: |
|
WuXi PharmaTech (Cayman) (NYSE:WX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
WuXi PharmaTech (Cayman) (NYSE:WX) Income Statement, Balance Sheet and Cash Flow Statement
WuXi PharmaTech (Cayman) (NYSE WX) Stock Chart for Thursday, May, 24, 2018
Loading chart…
